CLIMBERS AGAINST CANCER

Registered charity 1200162 · accounts filings on the Charity Commission register

We raise funds by selling merchandise from our office and online at our website. Our supporters also raise funds by holding events etc which they give to us to use for the donations that we make. We donate money to cancer research centres around the world. The money we donate goes directly into cancer research programmes in research centres.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£50k
Latest spending
£48k
Registered
2022
Accounts read
FY2024

Financial health, per its FY2024 accounts

The accounts state that unrestricted cash funds increased to £113,106 at year-end, with the trustees noting that reserves cover six months of running costs. The charity generated a surplus of £1,665 from unrestricted activities, while its trading subsidiary recovered prior losses with a profit of £19k. No material uncertainties or going concern issues were identified by the independent examiner.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Reserves policy: six months running costs (held: £113k)
The charity will have reserves of six months running costs — page 4
Per its FY2024 accounts as filed with the Charity Commission.
Trading subsidiary: Climbers Against Cancer Trading Limited
The charity owns 100% of the share capital in Climbers Against Cancer Trading Limited, company number 09197060. — page 3
Per its FY2024 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Public profiles (found on the charity’s own website): facebook · instagram

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England

Income and spending

Financial year endIncomeSpending
31/12/2024£50k£48k
31/12/2023£66k£48k

Common questions

Is CLIMBERS AGAINST CANCER financially healthy?

Per its FY2024 accounts: The accounts state that unrestricted cash funds increased to £113,106 at year-end, with the trustees noting that reserves cover six months of running costs. The charity generated a surplus of £1,665 from unrestricted activities, while its trading subsidiary recovered prior losses with a profit of £19k. No material uncertainties or going concern issues were identified by the independent examiner. Its FY2024 accounts were independently examined.